Ana María Castañeda-Meléndrez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ana María Castañeda-Meléndrez has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Aldo Francisco Clemente-Soto
Faculty of Chemical Biological Sciences, Autonomous University of Sinaloa, 80030 Culiacán Rosales, Sinaloa, Mexico
1 shared publication - Edwin Barrios-Villa
Departamento de Ciencias Químico-Biológicas y Agropecuarias, Universidad de Sonora, Caborca 83600, Sonora, Mexico
1 shared publication - María Elena Báez-Flores
Unidad de Investigaciones en Salud Pública Dra. Kaethe Willms, Facultad de Ciencias Químico Biológicas, Universidad Autónoma de Sinaloa
1 shared publication - Patricia Catalina García-Cervantes
Unit of Public Health Research "Dr. Kaethe Willms," Doctorate in Biomedical Sciences, Faculty of Chemical-Biological Sciences, Autonomous University of Sinaloa, University City, Culiacan, Sinaloa, Mexico
1 shared publication - Rodolfo Bernal-Reynaga
Faculty of Chemical Biological Sciences, Autonomous University of Sinaloa, 80030 Culiacán Rosales, Sinaloa, Mexico
1 shared publication
Latest Publications
- Open Access
- 1 January 2025
- Published by Wiley in International Journal of Microbiology
- Vol. 2025 (1) , 8881117
Virulence, Phylogenetic Grouping, and Antimicrobial Resistance Traits of Extraintestinal Escherichia coli in Clinical Isolates From Northwest Mexico
Escherichia coli is a highly diverse bacterial species that is canonically commensal; however, its genomic characteristics have enabled its evolution into pathogens capable of causing extraintestinal infections (ExPEC), which pose significant clinical challenges because of the variety of sites that can infect (mainly the urinary tract) and the multidrug resistance associated with these strains. The present study is aimed at characterizing ExPEC isolates recovered from the wards of a hospital in Sinaloa, Mexico, to establish their virulence and antimicrobial resistance profiles, as well as the phylogenetic group. Then, 200 Escherichia coli isolates and their antimicrobial susceptibility were confirmed by the VITEK‐2 automated system. Virulence factor genes and phylogenetic grouping were performed through endpoint and multiplex PCRs. Then, 59% of the strains produced extended‐spectrum β ‐lactamases (ESBLs), and 71.5% were classified as multidrug resistant (MDR), exhibiting high resistance rates to antibiotics such as amoxicillin, ampicillin, ciprofloxacin, and various cephalosporins. In this sense, 68.5% and 33% of the isolates were positive for the blaCTX-M1-8 and blaCTX-M9 genes, respectively, both associated with resistance to cefotaxime. Furthermore, 37% of the isolates harbored the blaOXA48 gene, which is linked to resistance to oxacillin‐type β ‐lactams. Moreover, 143 (71.5%) of them were classified as MDR. Regarding virulence, the distribution of toxin genes such as hlyA and vat was 16.5% and 24.5%, respectively. Adhesins papC and fimA were found in 62% and 34%, respectively. Additionally, the iron acquisition systems and outer membrane proteins such as iutA (74%), fyuA (63%), iroN (10%), agn43 (82%), and kpsmTII (34.5%) were present in the isolates. Phylogenetic analysis showed a predominance of group B2 (46%), followed by groups A (13.5%) and E (10.5%). These findings highlight the complexity and challenges posed by ExPEC strains in terms of antimicrobial resistance and virulence relevant to public health in hospital settings.
- 1 January 2025
- Published by Wiley in International Journal of Microbiology
- Vol. 2025 (1) , 8881117
Open AccessVirulence, Phylogenetic Grouping, and Antimicrobial Resistance Traits of Extraintestinal Escherichia coli in Clinical Isolates From Northwest Mexico
Escherichia coli is a highly diverse bacterial species that is canonically commensal; however, its genomic characteristics have enabled its evolution into pathogens capable of causing extraintestinal infections (ExPEC), which pose significant clinical challenges because of the variety of sites that can infect (mainly the urinary tract) and the multidrug resistance associated with these strains. The present study is aimed at characterizing ExPEC isolates recovered from the wards of a hospital in Sinaloa, Mexico, to establish their virulence and antimicrobial resistance profiles, as well as the phylogenetic group. Then, 200 Escherichia coli isolates and their antimicrobial susceptibility were confirmed by the VITEK‐2 automated system. Virulence factor genes and phylogenetic grouping were performed through endpoint and multiplex PCRs. Then, 59% of the strains produced extended‐spectrum β ‐lactamases (ESBLs), and 71.5% were classified as multidrug resistant (MDR), exhibiting high resistance rates to antibiotics such as amoxicillin, ampicillin, ciprofloxacin, and various cephalosporins. In this sense, 68.5% and 33% of the isolates were positive for the blaCTX-M1-8 and blaCTX-M9 genes, respectively, both associated with resistance to cefotaxime. Furthermore, 37% of the isolates harbored the blaOXA48 gene, which is linked to resistance to oxacillin‐type β ‐lactams. Moreover, 143 (71.5%) of them were classified as MDR. Regarding virulence, the distribution of toxin genes such as hlyA and vat was 16.5% and 24.5%, respectively. Adhesins papC and fimA were found in 62% and 34%, respectively. Additionally, the iron acquisition systems and outer membrane proteins such as iutA (74%), fyuA (63%), iroN (10%), agn43 (82%), and kpsmTII (34.5%) were present in the isolates. Phylogenetic analysis showed a predominance of group B2 (46%), followed by groups A (13.5%) and E (10.5%). These findings highlight the complexity and challenges posed by ExPEC strains in terms of antimicrobial resistance and virulence relevant to public health in hospital settings.